ANI Pharmaceuticals | ANIP - Stock


ANI Pharmaceuticals reported $143.15M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
ANI Pharmaceuticals USD 143.15M 319K Jun/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.29B 135M Mar/2026
Omeros USD 712K 266K Sep/2021
Perrigo USD 1.06B 56.9M Jun/2026
Sun Pharmaceuticals INR 114.93B 12.5B Mar/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026